Impact of tirzepatide treatment on participant‐reported food craving and food preference: Secondary analyses of a phase 1 randomised controlled trial in people with obesity with dietary restriction
Diabetes, Obesity and Metabolism · 2025-11 · 27 (11) · 6784-6789
DOI: 10.1111/dom.70063 ↗Kurz gefasst
Leserbrief in der Zeitschrift Diabetes, Obesity and Metabolism, online erschienen am 28.08.2025. Verfasst von Sam F Kennedy und 10 weiteren Autor:innen. Beteiligte Einrichtung: Pennington Biomedical Research Center, Baton Rouge, Louisiana, USA. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 8 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Eli Lilly and Company.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Pennington Biomedical Research Center, Baton Rouge, Louisiana, USA.
- Eli Lilly and Company, Indianapolis, Indiana, USA.
- Department of Physiology and Sport and Health University Research Institute (iMUDS), University of Granada, Granada, Spain.
- Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y Nutrición (CIBERobn), Instituto de Salud Carlos III, Madrid, Spain.
- Instituto de Investigación Biosanitaria (ibs.GRANADA), Granada, Spain.
ORCID-Profile: Alastair Knights, Edward J Pratt, Axel Haupt, Tamer Coskun, Corby K Martin
Förderung
- Eli Lilly and Company
Zitieren
APA
Kennedy, S. F., Knights, A., Ravussin, E., Sanchez-Delgado, G., Nishiyama, H., Qian, H. R., Pratt, E. J., Milicevic, Z., Haupt, A., Coskun, T., & Martin, C. K. (2025). Impact of tirzepatide treatment on participant‐reported food craving and food preference: Secondary analyses of a phase 1 randomised controlled trial in people with obesity with dietary restriction. Diabetes, Obesity and Metabolism, 27(11), 6784-6789. https://doi.org/10.1111/dom.70063
Vancouver
Kennedy SF, Knights A, Ravussin E, Sanchez-Delgado G, Nishiyama H, Qian HR, et al. Impact of tirzepatide treatment on participant‐reported food craving and food preference: Secondary analyses of a phase 1 randomised controlled trial in people with obesity with dietary restriction. Diabetes, Obesity and Metabolism. 2025;27(11):6784-6789. doi:10.1111/dom.70063
BibTeX
@article{Kennedy2025,
author = {Kennedy, Sam F and Knights, Alastair and Ravussin, Eric and Sanchez-Delgado, Guillermo and Nishiyama, Hiroshi and Qian, Hui-Rong and Pratt, Edward J and Milicevic, Zvonko and Haupt, Axel and Coskun, Tamer and Martin, Corby K},
title = {Impact of tirzepatide treatment on participant‐reported food craving and food preference: Secondary analyses of a phase 1 randomised controlled trial in people with obesity with dietary restriction},
journal = {Diabetes, Obesity and Metabolism},
year = {2025},
volume = {27},
number = {11},
pages = {6784--6789},
doi = {10.1111/dom.70063}
}
EUVIMED